65+ Flu Defense is a project of Immunize.org and CSL Seqirus. This collaboration aims to reach health care providers with information, tools, and resources they need to better communicate the impact of flu and its complications in older adults, and to proactively discuss flu vaccination with their patients aged 65 and older.

Immunize.org works to increase immunization rates and prevent disease through its practical educational materials designed to enhance the quality and safety of immunization services. We work with partners to advocate for policies that increase vaccination of people of all ages. We also facilitate communication about the safety, effectiveness, and use of vaccines within the broad immunization community of patients, parents, healthcare organizations, and government health agencies.

As a global leader in the protection of public health and one of the largest influenza vaccine providers in the world, CSL Seqirus is committed to preventing infectious diseases, like influenza and COVID-19, and is a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, and leading R&D capabilities, CSL Seqirus offers a broad portfolio of innovative, differentiated influenza vaccines in more than 20 countries around the world.